@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix pfh: . @prefix geneProductOf: . @prefix RNA: . @prefix hgnc: . @prefix species: . @prefix occursIn: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: pfh:RAS%20Family; a Protein: . sub:_2 geneProductOf: hgnc:3113; a RNA: . sub:_3 occursIn: species:9606; rdf:object sub:_2; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(PFH:\"RAS Family\") -> r(HGNC:E2F1)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "1.4" . sub:_4 dce:identifier "Weizmann Institute open day 2002: cancer research and therapy"; dce:title "Weizmann Institute open day 2002: cancer research and therapy"; dce:type "Other" . sub:_5 prov:value "The effect of Ras on up-regulation of E2F-1 mRNA is at the level of mRNA stability and the induced E2F-1 is transcriptional active."; prov:wasQuotedFrom sub:_4 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource sub:_4; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:29:44.236+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }